9 Meters Biopharma Inc. Stock Analysis NMTRQ
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. The company is headquartered in Raleigh, North Carolina and currently employs 10 full-time employees. The company went IPO on 2016-07-08. The firm has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.
Read More 9 Meters Biopharma Inc (NMTRQ) Chart
Key Statistics of 9 Meters Biopharma Inc (NMTRQ)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
800.00P/E Ratio (TTM)
-52 Week Range
Market Cap
14.00Avg. Volume
5091.50Dividend Yield
-Financial Metrics & Statements of 9 Meters Biopharma Inc (NMTRQ)
FAQ's for 9 Meters Biopharma Inc (NMTRQ)
- According to Musaffa’s Shariah screening methodology, 9 Meters Biopharma Inc (NMTRQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.